Fulgent Genetics, Inc. (FLGT) News

Fulgent Genetics, Inc. (FLGT): $34.76

1.47 (+4.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter FLGT News Items

FLGT News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

FLGT News Highlights

  • For FLGT, its 30 day story count is now at 2.
  • Over the past 19 days, the trend for FLGT's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest FLGT News From Around the Web

Below are the latest news stories about FULGENT GENETICS INC that investors may wish to consider to help them evaluate FLGT as an investment opportunity.

Fulgent Expands Board of Directors with Addition of Reggie Groves

TEMPLE CITY, Calif., January 03, 2023--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics", "Fulgent" or the "company") today announced the addition of Reggie Groves to its board of directors, effective January 3, 2023.

Yahoo | January 3, 2023

My Top 7 Strong Conviction Buys for 2023

Companies that are down on their luck this year are in strong contention for conviction buys for 2023 as they rebound.

Chris Lau on InvestorPlace | December 15, 2022

Do investors need to be concerned about Fulgent Genetics Inc. (FLGT)?

Fulgent Genetics Inc. (NASDAQ:FLGT) marked $33.70 per share on Thursday, down from a previous closing price of $37.07. While Fulgent Genetics Inc. has underperformed by -9.09%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, FLGT fell by -60.67%, with highs and lows ranging from $109.55 to […]

US Post News | December 9, 2022

Owning 45% shares,institutional owners seem interested in Fulgent Genetics, Inc. (NASDAQ:FLGT),

If you want to know who really controls Fulgent Genetics, Inc. ( NASDAQ:FLGT ), then you'll have to look at the makeup...

Yahoo | December 2, 2022

The 7 Best Mid-Cap Stocks to Buy Right Now

Those wanting growth potential without the stuffiness of the blue chips should consider the best mid-cap stocks to buy.

Josh Enomoto on InvestorPlace | December 1, 2022

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating certain directors and officers of Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT) for breaching their fiduciary duties to Fulgent and its shareholders. If you are a Fulgent shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or [email protected] Scott+Scott is investigating

Business Wire | November 28, 2022

A Look At Fulgent Genetics Inc. (FLGT) Stock Performance

Fulgent Genetics Inc. (NASDAQ:FLGT) concluded the trading at $36.89 on Friday, November 25, with a rise of 1.10% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $36.49 and 5Y monthly beta was reading 1.60 with its price kept floating in the … A Look At Fulgent Genetics Inc. (FLGT) Stock Performance Read More »

Stocks Register | November 26, 2022

1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings

Strong core business growth was overshadowed in Q3 by an acquisition.

The Motley Fool | November 24, 2022

FLGT 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact the Firm''s Attorneys Before Nov. 21st Deadline in Securities Class Action

SAN FRANCISCO, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT ) investors who suffered significant losses to submit your losses now . A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations. Class Period: Mar. 22, 2019 – Aug. 4, 2022 Lead Plaintiff Deadline: Nov. 21, 2022 Visit: www.hbsslaw.com/investor-fraud/FLGT Contact An Attorney Now: [email protected] 844-916-0895 Fulgent Genetics, Inc. (NASDAQ: FLGT ) Securities Fraud Class Action: The litigation focuses on Fulgent''s previously claimed "very strong" and "truly outstanding" financial results. The complaint alleges Defendants made materially false and misleading statements and failed to disclose that: (1) Fulgent had been conduct...

Benzinga | November 19, 2022

FLGT 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact the Firm’s Attorneys Before Nov. 21st Deadline in Securities Class Action

SAN FRANCISCO, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now . A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations.

GlobeNewswire | November 19, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4947 seconds.